Read aloud

Health professionals: Applying for access to the CGM Initiative through the NDSS

To access CGM and Flash GM products through the CGM Initiative as part of the NDSS, the person will need to be assessed by an authorised health professional to determine whether they meet specific eligibility criteria and decide which is the most suitable product for them to use as part of their diabetes management. Not all products are suitable for everyone.

Eligibility criteria

You can access details and information, relevant to the eligible groups, including eligibility criteria, directly from these links:

Submitting a standard application

To submit an application, a completed Continuous and flash glucose monitoring eligibility assessment form prepared and certified by an authorised health professional, should be:

Download a Continuous and flash glucose monitoring eligibility assessment form.

Resources

Frequently asked questions

This resource was developed for health professionals to provide general information on accessing CGM products through the NDSS, how you can help people applying for access, details about eligibility criteria and how to complete Continuous and flash glucose monitoring eligibility assessment forms.

Continuous glucose monitoring booklet

This booklet aims to provide information for health professionals about fully subsidised continuous glucose monitoring devices.

Indications for use

The CGM and Flash GM device summary and compatibility chart contains information about CGM and Flash GM devices fully subsidised through the CGM Initiative as part of the NDSS, their compatibility with insulin pumps and smartphone and smart devices, and links to guidelines about appropriate use, including manufacturers documentation.

The Therapeutic Goods Administration approves CGM and Flash GM devices that can be lawfully supplied in Australia and these are listed in the Australian Register of Therapeutic Goods (ARTG). 

By certifying Continuous and flash glucose monitoring eligibility assessment forms for a person, you are confirming that you are aware that not all CGM and Flash GM products are indicated for use in all conditions or all age groups, and that you have considered available advice about the selected device. This includes advice on the relevant ARTG listing about appropriate use for specific conditions.

The CGM and Flash GM device summary and compatibility chart contains links to the ARTG listings.

Submitting an extended access application

Sometimes pregnancy planning may need to continue after the initial 12 months. Applications for extensions require documented evidence of need from both a diabetes and a pregnancy health professional. This documentation should confirm ongoing active pregnancy planning.

Applications for an extension of access to CGM and Flash GM products for a further six-month period, are considered on a case-by-case basis. At the end of this six-month period, one further six-month extension may be granted subject to the same documentation being provided.

Find out more about: